Clinical value of macrogenome next-generation sequencing on infections

被引:0
|
作者
Han, Benfa [1 ]
Zhang, Xiaoli [1 ]
Li, Xiuxi [1 ]
Chen, Mei [1 ]
Ma, Yanlin [2 ]
Zhang, Yunxia [1 ]
Huo, Song [1 ]
机构
[1] First Peoples Hosp HongHe State, Southern Cent Hosp Yunnan Prov, Dept Infect Dis, Honghe 661000, Yunnan, Peoples R China
[2] Southern Cent Hosp Yunnan Prov, First Peoples Hosp HongHe State, Dept Pharmaceut, Honghe 661000, Yunnan, Peoples R China
来源
OPEN LIFE SCIENCES | 2024年 / 19卷 / 01期
关键词
intracranial infection; pathogen detection; mNGS technology; clinical analysis; efficacy evaluation; DIAGNOSIS; DNA;
D O I
10.1515/biol-2022-0938
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Intracranial infection (ICI) is a frequent and serious complication after neurosurgery. Macrogenome next-generation sequencing (mNGS) technology can provide reference for clinical diagnosis and treatment of ICI. This work aimed to explore the application value of mNGS technology in analyzing the clinical characteristics of human immunodeficiency virus (HIV) infection and ICI after neurosurgery. A total of 60 patients with ICI were enrolled as the research objects, all patients underwent routine cerebrospinal fluid analysis and traditional pathogen detection, followed by mNGS genome analysis. Using clinical diagnosis of ICI as the gold standard, the sensitivity, specificity, positive predictive value, and negative predictive value for both detection methods were calculated. Receiver operating characteristic curves were constructed to assess the area under the curve (AUC) for evaluating the clinical value of mNGS in suspected intracranial infectious pathogen diagnosis. Results showed a positivity rate of 71.67% (43 cases) with mNGS compared to 28.33% (17 cases) with traditional pathogen detection methods, demonstrating a significant difference (P < 0.05). The sensitivity of mNGS for detecting ICIs was 83.7%, significantly higher than the 34.88% observed with traditional methods (P < 0.05). The pathogen detection rate of mNGS was higher than traditional methods (P = 0.002), with an AUC of 0.856 (95% CI: 0.638-0.967), significantly greater than the AUC of 0.572 (95% CI: 0.350-0.792) for traditional methods (P < 0.05). mNGS successfully identified microorganisms such as Cryptococcus, Propionibacterium, Staphylococcus, Corynebacterium, Micrococcus, and Candida associated with ICIs. These findings underscore the clinical applicability of mNGS technology in analyzing the characteristics of HIV infection and ICI post-neurosurgical procedures. This technology enables more accurate diagnosis and treatment of ICIs, providing valuable insights for developing effective therapeutic strategies. Graphical abstract
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Next-Generation Sequencing to Guide Clinical Trials
    Siu, Lillian L.
    Conley, Barbara A.
    Boerner, Scott
    LoRusso, Patricia M.
    CLINICAL CANCER RESEARCH, 2015, 21 (20) : 4536 - 4544
  • [32] Clinical Applications and Limitations of Next-Generation Sequencing
    Basho, Reva Kakkar
    Eterovic, Agda Karina
    Meric-Bernstam, Funda
    AMERICAN JOURNAL OF HEMATOLOGY-ONCOLOGY, 2015, 11 (03) : 17 - 22
  • [33] Implementing Next-Generation Sequencing in Clinical Practice
    Watkins, Nicholas A.
    Charames, George S.
    JOURNAL OF APPLIED LABORATORY MEDICINE, 2018, 3 (02): : 338 - 341
  • [34] Next-generation DNA sequencing in clinical diagnostics
    Lacoste, C.
    Fabre, A.
    Pecheux, C.
    Levy, N.
    Krahn, M.
    Malzac, P.
    Bonello-Palot, N.
    Badens, C.
    Bourgeois, P.
    ARCHIVES DE PEDIATRIE, 2017, 24 (04): : 373 - 383
  • [35] Next-generation sequencing technology in clinical virology
    Capobianchi, M. R.
    Giombini, E.
    Rozera, G.
    CLINICAL MICROBIOLOGY AND INFECTION, 2013, 19 (01) : 15 - 22
  • [36] Next-generation sequencing for clinical HLA typing
    Chengyu Wu
    Qiang Shi
    Dinh Pham
    Afzal Nikaein
    实用器官移植电子杂志, 2018, 6 (04) : 275 - 285
  • [37] Next-generation sequencing and its clinical application
    Qin, Dahui
    CANCER BIOLOGY & MEDICINE, 2019, 16 (01) : 4 - 10
  • [38] Clinical Integration of Next-Generation Sequencing Technology
    Gullapalli, R. R.
    Lyons-Weiler, M.
    Petrosko, P.
    Dhir, R.
    Becich, M. J.
    LaFramboise, W. A.
    CLINICS IN LABORATORY MEDICINE, 2012, 32 (04) : 585 - +
  • [39] Clinical next-generation sequencing in sarcomas.
    Groisberg, Roman
    Hong, David S.
    Janku, Filip
    Piha-Paul, Sarina Anne
    Ravi, Vinod
    Benjamin, Robert S.
    Patel, Shreyaskumar
    Somaiah, Neeta
    Conley, Anthony Paul
    Herzog, Cynthia E.
    Meric-Bernstam, Funda
    Subbiah, Vivek
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [40] Metagenomic next-generation sequencing in clinical microbiology
    Jacob, Jobin John
    Veeraraghavan, Balaji
    Vasudevan, Karthick
    INDIAN JOURNAL OF MEDICAL MICROBIOLOGY, 2019, 37 (02) : 133 - 140